Correlation Between Cullinan Oncology and PepGen
Can any of the company-specific risk be diversified away by investing in both Cullinan Oncology and PepGen at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cullinan Oncology and PepGen into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cullinan Oncology LLC and PepGen, you can compare the effects of market volatilities on Cullinan Oncology and PepGen and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cullinan Oncology with a short position of PepGen. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cullinan Oncology and PepGen.
Diversification Opportunities for Cullinan Oncology and PepGen
0.75 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Cullinan and PepGen is 0.75. Overlapping area represents the amount of risk that can be diversified away by holding Cullinan Oncology LLC and PepGen in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on PepGen and Cullinan Oncology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cullinan Oncology LLC are associated (or correlated) with PepGen. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of PepGen has no effect on the direction of Cullinan Oncology i.e., Cullinan Oncology and PepGen go up and down completely randomly.
Pair Corralation between Cullinan Oncology and PepGen
Given the investment horizon of 90 days Cullinan Oncology LLC is expected to generate 0.65 times more return on investment than PepGen. However, Cullinan Oncology LLC is 1.53 times less risky than PepGen. It trades about 0.05 of its potential returns per unit of risk. PepGen is currently generating about 0.02 per unit of risk. If you would invest 869.00 in Cullinan Oncology LLC on August 25, 2024 and sell it today you would earn a total of 385.00 from holding Cullinan Oncology LLC or generate 44.3% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
Cullinan Oncology LLC vs. PepGen
Performance |
Timeline |
Cullinan Oncology LLC |
PepGen |
Cullinan Oncology and PepGen Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Cullinan Oncology and PepGen
The main advantage of trading using opposite Cullinan Oncology and PepGen positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cullinan Oncology position performs unexpectedly, PepGen can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in PepGen will offset losses from the drop in PepGen's long position.Cullinan Oncology vs. Eliem Therapeutics | Cullinan Oncology vs. HCW Biologics | Cullinan Oncology vs. RenovoRx | Cullinan Oncology vs. Tempest Therapeutics |
PepGen vs. Pmv Pharmaceuticals | PepGen vs. Eliem Therapeutics | PepGen vs. MediciNova | PepGen vs. Pharvaris BV |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Other Complementary Tools
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |